News Conference News NY Valves 2025 Solid, Early Surgical Results With Polymer Mitral Valve Todd Neale July 02, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TVT 2023 Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes Michael O'Riordan June 13, 2023
News Conference News ACC 2023 Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients Todd Neale March 05, 2023
News Conference News TCT 2021 SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years Todd Neale November 05, 2021
News Daily News EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management L.A. McKeown September 22, 2021
News Daily News Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition Michael O'Riordan January 26, 2018
News Conference News TCT 2015 Companies With Innovative Technologies Compete in TCT Shark Tank October 13, 2015
News Industry News First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate May 19, 2015
News Daily News PARTNER Cohort A Published: Surgical Candidates Obtain Similar 1-Year Survival with TAVI, Surgery L.A. McKeown June 07, 2011